var data={"title":"Overview of vitamin E","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Overview of vitamin E</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/contributors\" class=\"contributor contributor_credentials\">Sassan Pazirandeh, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/contributors\" class=\"contributor contributor_credentials\">David L Burns, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/contributors\" class=\"contributor contributor_credentials\">David Seres, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/contributors\" class=\"contributor contributor_credentials\">Kathleen J Motil, MD, PhD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/contributors\" class=\"contributor contributor_credentials\">Alison G Hoppin, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Oct 03, 2016.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Vitamins are a number of chemically unrelated families of organic substances that cannot be synthesized by humans but need to be ingested in the diet in small quantities to prevent disorders of metabolism. They are divided into water-soluble and fat-soluble vitamins (<a href=\"image.htm?imageKey=PEDS%2F63827\" class=\"graphic graphic_table graphicRef63827 \">table 1</a>).</p><p>In 1922, Evans and Bishop discovered a substance that was deficient in rats fed a diet that contained lard and that resulted in infertility [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/1\" class=\"abstract_t\">1</a>]. The deficiency was corrected when a lipid extract of cereals was added to the diet; this was termed the &quot;anti-sterility factor&quot; [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/2\" class=\"abstract_t\">2</a>]. In 1925, <a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">vitamin E</a> was officially recognized as the fifth vitamin. A few years later the name tocopherol from the Greek word of &quot;toc&quot; (child) and &quot;phero&quot; (to bring forth) was coined to describe its role as an essential dietary substance in normal fetal and childhood development [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/3\" class=\"abstract_t\">3</a>]. In 1969, the FDA formally recognized vitamin E as an essential nutrient for humans. Vitamin E is a fat-soluble compound and an antioxidant and protects cell membranes from oxidation and destruction.</p><p>This topic review will focus on <a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">vitamin E</a>. Overviews of the other fat-soluble vitamins, minerals and water-soluble vitamins are available elsewhere. (See <a href=\"topic.htm?path=overview-of-vitamin-a\" class=\"medical medical_review\">&quot;Overview of vitamin A&quot;</a> and <a href=\"topic.htm?path=overview-of-vitamin-d\" class=\"medical medical_review\">&quot;Overview of vitamin D&quot;</a> and <a href=\"topic.htm?path=overview-of-vitamin-k\" class=\"medical medical_review\">&quot;Overview of vitamin K&quot;</a> and <a href=\"topic.htm?path=overview-of-dietary-trace-minerals\" class=\"medical medical_review\">&quot;Overview of dietary trace minerals&quot;</a> and <a href=\"topic.htm?path=overview-of-water-soluble-vitamins\" class=\"medical medical_review\">&quot;Overview of water-soluble vitamins&quot;</a> and <a href=\"topic.htm?path=vitamin-supplementation-in-disease-prevention\" class=\"medical medical_review\">&quot;Vitamin supplementation in disease prevention&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">SOURCES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">Vitamin E</a> is found in a variety of foods including oils, meat, eggs, and leafy vegetables. The form that is best known for its role in human health is alpha-tocopherol, which is abundant in olive and sunflower oils, and is the predominant form in the European diet. Gamma-tocopherol is another form, which is abundant in soybean and corn oil, and is common in the American diet.</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">CHEMISTRY AND NOMENCLATURE</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The primary bioactive form of <a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">vitamin E</a> is alpha-tocopherol. Alpha-tocopherol has eight isomers, but only four of these (RRR-, RSR-, RRS-, and RSS- alpha-tocopherol) are efficiently maintained in human plasma, and these are the forms to which the dietary reference intakes apply [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/4\" class=\"abstract_t\">4</a>]. Furthermore, the RRR-isomer (formerly and incorrectly called D-alpha-tocopherol) is the only form found in foods; it is sometimes known as &quot;natural source&quot; vitamin E. </p><p>Many synthetic <a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">vitamin E</a> supplements or fortified foods contain all the eight isomers of alpha-tocopherol; these are known as &quot;all racemic&quot; or &quot;DL&quot; alpha tocopherol, and have approximately half of the activity of &quot;natural source&quot; vitamin E. However, all of the isomers of alpha tocopherol may contribute to the potential adverse effects of supplemental vitamin E and are included in the calculation of an upper limit for supplementation [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/4\" class=\"abstract_t\">4</a>]. &#160;</p><p><a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">Vitamin E</a> dosing is quantified by the content of the active isomer: </p><div class=\"formulaContainer\"><div class=\"formula\"><p class=\"bulletIndent1\">1 mg RRR-alpha tocopherol = 1.47 international units &quot;natural source&quot; <a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">vitamin E</a> (D-alpha-tocopherol) = 2.2 international units &quot;all racemic&quot; vitamin E (DL-alpha-tocopherol). </p></div></div><p/><p>Seven other naturally occurring <a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">vitamin E</a> compounds have been described: beta-, gamma-, and delta-tocopherol; and alpha-, beta-, gamma- and delta-tocotrienols. Nutrient databases, especially older data sources, often report either total tocopherol concentrations, or &quot;alpha-tocopherol equivalents,&quot; which adjusts for the bioavailability for the various forms [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/4\" class=\"abstract_t\">4</a>]. However, these measures do not reflect the bioactivity of alpha-tocopherol, which is now used as the standard for dietary sufficiency. </p><p>Gamma-tocopherol is transported less efficiently and has lower plasma levels, but similar tissue levels as compared with alpha-tocotrienols [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/5\" class=\"abstract_t\">5</a>]. Because gamma-tocopherol has unique associations with inflammation and airway hyperresponsiveness (see <a href=\"#H4\" class=\"local\">'Actions'</a> below), this compound may have important adverse or beneficial effects, although it is not currently included in the recommended daily allowance (RDA). Pharmacological doses of alpha-tocopherol taken in supplements reduce levels of gamma-tocopherol in plasma [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/5,6\" class=\"abstract_t\">5,6</a>]. </p><p>In most reports and in this topic review, the term &quot;<a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">vitamin E</a>&quot; refers to the biologically active isomers of alpha-tocopherol, unless otherwise specified.</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h1\">ACTIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">Vitamin E</a> (as alpha-tocopherol) works as a free radical scavenger, protecting polyunsaturated fatty acids (PUFA), a major structural component of the cell membranes, from peroxidation [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/7\" class=\"abstract_t\">7</a>]. In the past few decades, there has been increasing interest in the role of free radicals and anti-oxidants in atherosclerosis and carcinogenesis (see <a href=\"topic.htm?path=vitamin-supplementation-in-disease-prevention\" class=\"medical medical_review\">&quot;Vitamin supplementation in disease prevention&quot;</a>). Deficiency of vitamin E has been connected to cardiovascular events. Low-density lipoprotein (LDL) plays a central role in these hypotheses. When LDL is exposed to oxidative stress, it undergoes a cascade of changes affecting the vascular endothelium, thereby facilitating atherogenesis [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/8-10\" class=\"abstract_t\">8-10</a>]. This theory is referred to as the oxidative modification hypothesis, and has fueled epidemiologic studies and clinical trials in cardiology to determine the role of antioxidants, such as vitamin E, in prevention and treatment of atherosclerotic cardiovascular disease [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/11\" class=\"abstract_t\">11</a>]. However, trials of vitamin E supplementation (which typically use &quot;all-racemic&quot; vitamin E) have generally shown no effect in prevention of heart disease. (See <a href=\"topic.htm?path=nutritional-antioxidants-in-coronary-heart-disease\" class=\"medical medical_review\">&quot;Nutritional antioxidants in coronary heart disease&quot;</a> and <a href=\"topic.htm?path=vitamin-supplementation-in-disease-prevention\" class=\"medical medical_review\">&quot;Vitamin supplementation in disease prevention&quot;</a>.)</p><p>Gamma-tocopherol appears to promote eosinophilic lung inflammation and airway hyperresponsiveness [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/12,13\" class=\"abstract_t\">12,13</a>], although it also may oppose neutrophil-mediated inflammation, mediated by reductions in prostaglandin E2 [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/14,15\" class=\"abstract_t\">14,15</a>]. The overall health effects of gamma-tocopherol have not been established. High doses of <a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">vitamin E</a> (as alpha-tocopherol) reduce levels of gamma-tocopherol, perhaps explaining the adverse effects of pharmacological doses of the vitamin [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/5,6\" class=\"abstract_t\">5,6</a>]. </p><p>Some functions of <a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">vitamin E</a> are independent of the <span class=\"nowrap\">antioxidant/radical</span> scavenging activity, including inhibition of cell proliferation, platelet aggregation, and monocyte adhesion [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/16\" class=\"abstract_t\">16</a>]. Several other effects at the molecular level have been identified, but the clinical implications of these actions have not been established.</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h1\">METABOLISM</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Like other fat-soluble vitamins, bioavailability of alpha-tocopherol depends upon physiologic mechanisms for fat digestion and absorption. This process requires lingual and gastric lipases, bile salts and the production of mixed micelles, pancreatic function, intestinal and ileal mucosal and absorptive mechanisms. Bile salts and pancreatic enzymes are particularly important for intraluminal digestion of fat [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/17\" class=\"abstract_t\">17</a>]. Pancreatic esterases are the enzymes responsible for breaking down the tocopheryl-ester bonds between alpha-tocopherol and fatty acids [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/18\" class=\"abstract_t\">18</a>]. Within the intestinal mucosal cells, chylomicrons are produced from phospholipids, triglycerides, apolipoproteins, and fat-soluble vitamins. The synthesis of chylomicrons is required for transport of alpha-tocopherol via the lymphatic system to the liver [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/19\" class=\"abstract_t\">19</a>]. Within hepatocytes, chylomicron remnants are broken down by lysosomes, and RRR-alpha-tocopherol is preferentially secreted into the bloodstream, packaged within very-low-density lipoprotein (VLDL) molecules [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/20\" class=\"abstract_t\">20</a>]. The transport protein for alpha-tocopherol is named alpha-tocopherol transfer protein (A-TTP) [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/21\" class=\"abstract_t\">21</a>]. </p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h1\">REQUIREMENTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Dietary <a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">vitamin E</a> content is variable and proportional to vegetable oil intake. American diets of 2000 to 3000 <span class=\"nowrap\">kcal/day</span> contain 7 to 10 mg of alpha-tocopherol equivalents. However, this is likely an underestimate because dietary fat intake is commonly under-reported. &#160;</p><p class=\"headingAnchor\" id=\"H26561062\"><span class=\"h2\">Healthy population</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The recommended daily allowance (RDA) for <a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">vitamin E</a> is 15 mg of dietary alpha-tocopherol per day for adolescents and adult men and women, as defined by the United States National Academy of Sciences Food and Nutrition Board [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/4\" class=\"abstract_t\">4</a>]. This is the equivalent of 22 international units of RRR-alpha-tocopherol (the form that is supplied by some supplements and is marketed as &quot;natural-source&quot; vitamin E), or 33 international units of all-rac-alpha-tocopherol (the synthetic form used for the majority of supplements) [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/4\" class=\"abstract_t\">4</a>]. In children, the RDA rises from 6 mg at 1 to 3 years of age to 15 mg by 14 to 18 years (<a href=\"image.htm?imageKey=PEDS%2F81151\" class=\"graphic graphic_table graphicRef81151 \">table 2</a>). Note that although the requirements are stated in terms of alpha-tocopherol equivalents, a substantial portion of this will be provided as gamma-tocopherol if dietary sources are used. For this reason, dietary vitamin E may have advantages over vitamin E taken as a supplement. (See <a href=\"#H3\" class=\"local\">'Chemistry and nomenclature'</a> above and <a href=\"#H4\" class=\"local\">'Actions'</a> above.) &#160;</p><p class=\"headingAnchor\" id=\"H26561069\"><span class=\"h2\">Fat malabsorption</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with fat malabsorption are at risk for <a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">vitamin E</a> deficiency because of malabsorption of fat and fat-soluble vitamins; in most cases this is caused by a pancreatic, hepatic, or intestinal disorder. (See <a href=\"#H3459898355\" class=\"local\">'Causes'</a> below.) &#160;</p><p>If <a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">vitamin E</a> deficiency is diagnosed, these patients are treated with large oral doses of vitamin E. Water-miscible vitamin E (d-alpha-tocopherol glycol 1000 succinate, TPGS) is most effective in these patients [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/22\" class=\"abstract_t\">22</a>]. However, water-miscible preparations have not been shown to be superior for patients with cystic fibrosis who are taking concurrent pancreatic enzyme supplements [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/23,24\" class=\"abstract_t\">23,24</a>]. </p><p>Typical supplementation regimens for infants and children with cholestasis are 25 to 50 int. <span class=\"nowrap\">units/kg/day</span> of <a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">vitamin E</a> (alpha tocopherol), or 15 to 25 international <span class=\"nowrap\">units/kg/day</span> of water-miscible vitamin E [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/25,26\" class=\"abstract_t\">25,26</a>]. </p><p>The prevalence of <a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">vitamin E</a> deficiency in adults with cholestatic liver diseases has not been well defined. It is probably most common in patients with severe and prolonged primary biliary cholangitis, in whom estimates of vitamin E deficiency range from 10 to 50 percent [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/27-29\" class=\"abstract_t\">27-29</a>]. For patients with significant cholestasis (eg, bilirubin &gt;2.0 <span class=\"nowrap\">mg/dL),</span> routine monitoring of vitamin E levels is recommended, with vitamin E replacement as needed [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/30\" class=\"abstract_t\">30</a>]. </p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h1\">DEFICIENCY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">Vitamin E</a> deficiency is uncommon in humans except in unusual circumstances. This is due to the abundance of tocopherols in a wide variety of diets, including vegetarian and vegan diets. It occasionally occurs in individuals with severe protein-energy malnutrition [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/31\" class=\"abstract_t\">31</a>].</p><p class=\"headingAnchor\" id=\"H3459898355\"><span class=\"h2\">Causes</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">Vitamin E</a> deficiency is most commonly seen in patients with medical conditions that cause fat malabsorption. The degree of deficiency is generally proportional to the magnitude and duration of steatorrhea. Important causes of fat malabsorption are: </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pancreatic exocrine insufficiency &ndash; In which there is insufficient lipase to enable optimal fat absorption. Important causes are cystic fibrosis and chronic pancreatitis. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cholestatic liver disease &ndash; In which there is insufficient bile in the intestinal lumen to permit fat solubilization and absorption. Important causes include biliary atresia, primary sclerosing cholangitis, primary biliary cirrhosis, and familial intrahepatic cholestasis. Fat malabsorption may also be in other types of cirrhosis, although typically late in the course of the liver disease (decompensated cirrhosis). Patients with cholestasis also tend to have hyperlipidemia, which influences <a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">vitamin E</a> levels, so assessment of their vitamin E status requires simultaneous measurement of alpha-tocopherol and serum lipids. (See <a href=\"#H10\" class=\"local\">'Measurement'</a> below.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Extensive resection or disease affecting small intestine &ndash; In which there is insufficient intestinal absorptive area to permit fat absorption. If there is loss or disease of the terminal ileum, this may also cause malabsorption of bile acids and a diminished bile acid pool, which further contributes to fat malabsorption. Important causes include short bowel syndrome, congenital intestinal lymphangiectasia, and Crohn disease.</p><p/><p>Patients with these conditions typically require high maintenance doses of <a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">vitamin E</a>. (See <a href=\"#H26561069\" class=\"local\">'Fat malabsorption'</a> above.)</p><p>There are also several genetic disorders that lead to <a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">vitamin E</a> deficiency. As an example, a mutation in the gene encoding hepatic alpha-tocopherol transfer protein (TTPA) is associated with neurologic deficits and is known as ataxia with vitamin E deficiency (AVED). Affected patients have symptoms similar to Friedreich's ataxia [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/32\" class=\"abstract_t\">32</a>]. These patients sometimes respond to oral supplementation of vitamin E in doses of 800 to 1500 mg per day (or 40 <span class=\"nowrap\">mg/kg/day</span> in children) of alpha-tocopherol [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/33-35\" class=\"abstract_t\">33-35</a>]. More often, supplementation serves to prevent progression of the disease [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/36\" class=\"abstract_t\">36</a>]. (See <a href=\"topic.htm?path=overview-of-the-hereditary-ataxias#H18\" class=\"medical medical_review\">&quot;Overview of the hereditary ataxias&quot;, section on 'Treatable diseases'</a>.)</p><p class=\"headingAnchor\" id=\"H4250359426\"><span class=\"h2\">Clinical consequences</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In adults and children, <a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">vitamin E</a> deficiency can cause neuromuscular disorders and hemolysis. Low serum levels of vitamin E (defined as below 0.5 <span class=\"nowrap\">mg/dL)</span> may cause no appreciable symptoms, or may manifest as subtle neurologic abnormalities. Neuromuscular disorders associated with vitamin E deficiency are mostly of the neuropathic and myopathic type [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/36\" class=\"abstract_t\">36</a>]. The neuropathy generally consists of a spinocerebellar syndrome, with variable involvement of the peripheral nerves. Clinical manifestations include ataxia, hyporeflexia, and loss of proprioceptive and vibratory sensation [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/37\" class=\"abstract_t\">37</a>]. A skeletal myopathy and pigmented retinopathy also may be present [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/36,37\" class=\"abstract_t\">36,37</a>]. Brown bowel syndrome (intestinal lipofuscinosis) is a brown pigmentation of the bowel that occasionally presents with bowel dilatation and pseudo-obstruction [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/38,39\" class=\"abstract_t\">38,39</a>]. It is a rare complication of chronic vitamin E deficiency, and is thought to be caused by lipofuscin accumulation within the smooth muscle mitochondria. </p><p><a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">Vitamin E</a> deficiency can shorten the lifespan of red blood cells. In premature infants, vitamin E deficiency may cause a hemolytic anemia [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/40\" class=\"abstract_t\">40</a>]. Congenital hemolytic disorders such as thalassemia, sickle cell anemia, glucose-6-phosphate dehydrogenase deficiency (G6PD), and spherocytosis may be associated with low vitamin E plasma levels, likely because of increased oxidant stress and antioxidant consumption [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/41-43\" class=\"abstract_t\">41-43</a>]. Oral therapy with vitamin E supplementation may be of benefit, but efficacy has not been proven [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/44,45\" class=\"abstract_t\">44,45</a>].</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h1\">EXCESS AND TOXICITY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The long-term effects and the safety of <a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">vitamin E</a> supplementation are unclear [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/46\" class=\"abstract_t\">46</a>]. The Tolerable Upper Intake Level (UL) for vitamin E consumption from supplements is based primarily on concerns for hemorrhagic effects [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/4\" class=\"abstract_t\">4</a>]. The recommended UL is 1000 mg of alpha-tocopherol daily (approximately 1,500 international units of natural source or 2,200 international units of synthetic vitamin E) for adults without fat malabsorption or other cause of vitamin E malabsorption. The UL in children rises from 200 mg daily at 1 to 3 years to 600 mg daily at 9 to 13 years (<a href=\"image.htm?imageKey=PEDS%2F81151\" class=\"graphic graphic_table graphicRef81151 \">table 2</a>). Because of increasing evidence showing adverse effects of pharmacologic doses of vitamin E, it is possible that this UL is too high [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/47,48\" class=\"abstract_t\">47,48</a>]. We do not recommend supplementation near this level except when necessary to correct a deficiency state.</p><p>Most studies suggest that pharmacological doses of <a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">vitamin E</a> supplementation in doses of 100 to 400 international units (67 to 272 mg RRR-alpha tocopherol) per day are safe for most patients [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/11\" class=\"abstract_t\">11</a>]. However, other reports caution against the use of higher doses. One study, for example, found a higher evidence of mortality due to hemorrhagic strokes in vitamin E supplementation [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/8\" class=\"abstract_t\">8</a>]. Other studies caution against the use of vitamin E in patients with an increased propensity to bleeding or those taking vitamin K antagonist anticoagulants such as <a href=\"topic.htm?path=warfarin-drug-information\" class=\"drug drug_general\">warfarin</a>. Animal models have demonstrated impaired absorption of fat-soluble vitamins A and K with large vitamin E supplements. Large oral supplements of vitamin E have been associated with necrotizing enterocolitis in infants [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/49\" class=\"abstract_t\">49</a>]. Vitamin E may impair the hematologic response to iron in children with iron-deficiency anemia.</p><p>A meta-analysis examined the dose-response relationship between <a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">vitamin E</a> and overall mortality in a total of 19 randomized clinical trials which included a total of 135,967 participants [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/47\" class=\"abstract_t\">47</a>]. Doses of vitamin E ranged from 16.5 to 2000 <span class=\"nowrap\">IU/day</span> (median, 400 IU). Vitamin E supplementation with a dose &ge;400 <span class=\"nowrap\">IU/day</span> was associated with a significantly increased risk of all-cause mortality (95% CI 3-74 per 10,000 persons). Thus, patients without special indications should not take vitamin E supplements for disease prevention. (See <a href=\"topic.htm?path=vitamin-supplementation-in-disease-prevention#H26\" class=\"medical medical_review\">&quot;Vitamin supplementation in disease prevention&quot;, section on 'Vitamin E'</a>.)</p><p>Although significant, these findings should be interpreted with some caution since trials of high dose <a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">vitamin E</a> were small, and most of these included patients with chronic diseases. Furthermore, there was heterogeneity among the studies that showed an increase in all-cause mortality.</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h1\">THERAPEUTIC ROLES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The benefit of <a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">vitamin E</a> supplementation in pharmacologic doses on cancer, cardiovascular disease, stroke, dementia, and liver disease (such as nonalcoholic fatty liver disease) continue to be evaluated. A benefit of supplementation in cardiovascular disease appears to be unlikely. (See <a href=\"topic.htm?path=vitamin-supplementation-in-disease-prevention\" class=\"medical medical_review\">&quot;Vitamin supplementation in disease prevention&quot;</a> and <a href=\"topic.htm?path=nutritional-antioxidants-in-coronary-heart-disease\" class=\"medical medical_review\">&quot;Nutritional antioxidants in coronary heart disease&quot;</a> and <a href=\"topic.htm?path=chemoprevention-strategies-in-prostate-cancer\" class=\"medical medical_review\">&quot;Chemoprevention strategies in prostate cancer&quot;</a> and <a href=\"topic.htm?path=natural-history-and-management-of-nonalcoholic-fatty-liver-disease-in-adults\" class=\"medical medical_review\">&quot;Natural history and management of nonalcoholic fatty liver disease in adults&quot;</a>.)</p><p>In premature infants, hemolytic anemia is a common abnormality encountered in the presence of <a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">vitamin E</a> deficiency. Vitamin E therapy slightly increases hemoglobin concentrations and reduces the incidence of periventricular hemorrhage [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/50\" class=\"abstract_t\">50</a>]. However, the risk of sepsis also was increased with high-dose supplementation, regardless of whether administered by intravenous or oral routes. A few studies suggest some benefit in preventing retinopathy of prematurity, but overall the evidence is inconclusive [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/50-53\" class=\"abstract_t\">50-53</a>].</p><p>Some studies suggest some association between development of Alzheimer disease and <a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">vitamin E</a> deficiency [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/54\" class=\"abstract_t\">54</a>]. However, randomized trials suggest that vitamin E supplementation does not affect the risk of cognitive impairment or dementia [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/55\" class=\"abstract_t\">55</a>], but a possible role for slowing progression of Alzheimer disease. (See <a href=\"topic.htm?path=vitamin-supplementation-in-disease-prevention\" class=\"medical medical_review\">&quot;Vitamin supplementation in disease prevention&quot;</a> and <a href=\"topic.htm?path=treatment-of-dementia#H6\" class=\"medical medical_review\">&quot;Treatment of dementia&quot;, section on 'Antioxidants'</a>.)</p><p>Although controversial, a few studies support potential benefits of <a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">vitamin E</a> supplementation in treating cataracts or age-related macular degeneration [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/52,56,57\" class=\"abstract_t\">52,56,57</a>]. (See <a href=\"topic.htm?path=age-related-macular-degeneration-clinical-presentation-etiology-and-diagnosis#H11\" class=\"medical medical_review\">&quot;Age-related macular degeneration: Clinical presentation, etiology, and diagnosis&quot;, section on 'Risk factors'</a>.)</p><p>Some studies suggest benefit in preventing or treating tardive dyskinesia [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/58\" class=\"abstract_t\">58</a>]. A meta-analysis concluded that it may protect against deterioration of tardive dyskinesia, but probably does not improve symptoms [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/59\" class=\"abstract_t\">59</a>]. (See <a href=\"topic.htm?path=pharmacotherapy-for-schizophrenia-side-effect-management#H28219052\" class=\"medical medical_review\">&quot;Pharmacotherapy for schizophrenia: Side effect management&quot;, section on 'Tardive dyskinesia'</a>.)</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h1\">MEASUREMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>For patients with normal levels of serum lipids, serum alpha-tocopherol levels provide an adequate estimate of <a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">vitamin E</a> sufficiency. Alpha-tocopherol levels of less than 0.5 <span class=\"nowrap\">mg/dL</span> (5 <span class=\"nowrap\">&micro;g/mL,</span> or 11.5 <span class=\"nowrap\">&micro;mol/L)</span> are considered deficient. In a United States national survey, the 5th percentile for serum levels of vitamin E was 0.62 <span class=\"nowrap\">mg/dL</span> (14.3 <span class=\"nowrap\">&micro;mol/L),</span> and the 25th percentile was 0.79 <span class=\"nowrap\">mg/dL</span> (18.5 <span class=\"nowrap\">&micro;mol/L)</span> [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/4\" class=\"abstract_t\">4</a>].</p><p>For patients with marked hyperlipidemia, the serum <a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">vitamin E</a> level does not accurately reflect tissue vitamin levels. In these patients, the patient's vitamin E status can be estimated using the following ratio [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/60\" class=\"abstract_t\">60</a>]: </p><div class=\"formulaContainer\"><div class=\"formula\"><p>Effective serum <a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">vitamin E</a> level = Alpha-tocopherol <span class=\"nowrap\">/</span> (cholesterol + triglycerides)</p></div></div><p>A normal ratio is &gt;0.8 mg <span class=\"nowrap\">alpha-tocopherol/gram</span> total lipids.</p><p class=\"headingAnchor\" id=\"H811983305\"><span class=\"h1\">SOCIETY GUIDELINE LINKS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See <a href=\"topic.htm?path=society-guideline-links-vitamin-deficiencies\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Vitamin deficiencies&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">Vitamin E</a> (tocopherol) is a fat-soluble vitamin with antioxidant properties; it protects cell membranes from oxidation and destruction. Vitamin E is found in a variety of foods including oils, meat, eggs, and leafy vegetables. (See <a href=\"#H6\" class=\"local\">'Requirements'</a> above and <a href=\"#H4\" class=\"local\">'Actions'</a> above.) &#160;</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>There are multiple forms and isomers of tocopherol and the related compounds, tocotrienols. The best current evidence suggests that the primary bioactive form of <a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">Vitamin E</a> is alpha-tocopherol. This is quantified according to the presence of the RRR-isomer, which is the only form found in nature, and is also called &quot;natural source vitamin E&quot;, or D-alpha-tocopherol. Synthetic vitamin E contains seven other isomers (termed &quot;all-racemic vitamin E&quot; or DL-alpha-tocopherol), and has lower activity and possibly more toxic potential than the RRR-isomer. (See <a href=\"#H3\" class=\"local\">'Chemistry and nomenclature'</a> above and <a href=\"#H4\" class=\"local\">'Actions'</a> above.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Measurement of serum alpha-tocopherol concentrations provides an accurate measure of <a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">vitamin E</a> status for most patients, in the absence of hyperlipidemia. For patients with hyperlipidemia, effective vitamin E levels are calculated as the ratio of serum alpha-tocopherol per gram total lipids. (See <a href=\"#H10\" class=\"local\">'Measurement'</a> above.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Gamma-tocopherol is also present in foods. It is transported less efficiently and has lower plasma levels than alpha-tocopherol, but similar tissue levels are achieved. The overall health effects of gamma-tocopherol have not been established. (See <a href=\"#H3\" class=\"local\">'Chemistry and nomenclature'</a> above and <a href=\"#H4\" class=\"local\">'Actions'</a> above.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Absorption of dietary <a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">vitamin E</a> requires fully functional mechanisms for fat absorption, including lingual and gastric lipases, bile salts and the production of mixed micelles, pancreatic function, intestinal and ileal mucosal and absorptive mechanisms, unless provided in a synthetic water-soluble form. In addition, a specific protein (alpha-tocopherol transfer protein) is required for effective transport and use. (See <a href=\"#H5\" class=\"local\">'Metabolism'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Signs and symptoms of <a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">vitamin E</a> deficiency include hemolysis, neuromuscular disorders, ataxia, and peripheral neuropathy. Because of an abundance of tocopherols in the human diet, vitamin E deficiency is rare except in individuals with cholestatic liver disease, pancreatic insufficiency, or other conditions causing substantial fat malabsorption, or protein-energy malnutrition. Vitamin E deficiency also may be caused by rare genetic defects affecting vitamin E metabolism or transport. (See <a href=\"#H7\" class=\"local\">'Deficiency'</a> above.) &#160;</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>No syndrome of acute <a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">vitamin E</a> toxicity has been described. In premature infants, high-dose vitamin E treatment was associated with increased risk for sepsis (see <a href=\"#H9\" class=\"local\">'Therapeutic roles'</a> above). Chronic intake of supplements of pharmacologic doses in excess of 400 international units (272 mg RRR-alpha-tocopherol) daily has been associated with increased risk of hemorrhage and all-cause mortality. (See <a href=\"#H8\" class=\"local\">'Excess and toxicity'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>There is no evidence that supplementation of <a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">vitamin E</a> improves health outcomes in healthy children or adults. We suggest that patients without special indications avoid taking daily supplements containing high doses (&gt;400 IU) of vitamin E (<a href=\"grade.htm?i=5\" class=\"grade\">Grade 2B</a>). (See <a href=\"#H8\" class=\"local\">'Excess and toxicity'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Individuals with severe pancreatic insufficiency or cholestatic liver disease may have <a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">vitamin E</a> deficiency due to fat malabsorption. For these individuals, we recommend vitamin E supplementation (<a href=\"grade.htm?i=1\" class=\"grade\">Grade 1A</a>). Doses of about 25 to 50 international <span class=\"nowrap\">units/kg/day</span> (17 to 34 mg RRR-alpha-tocopherol) are generally effective in children. Alternatively, water miscible vitamin E can be used to maximize absorption, at a dose of 15 to 25 international <span class=\"nowrap\">units/kg/day</span>. (See <a href=\"#H6\" class=\"local\">'Requirements'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Current evidence does not support a role for <a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">vitamin E</a> supplementation in the prevention or treatment of cancers, cardiovascular and cerebrovascular disease, dementia, and retinopathy of prematurity. Weak evidence suggests a possible role in slowing the progression of Alzheimer disease, tardive dyskinesia, and macular degeneration. In premature infants, vitamin E supplementation may reduce the risk of periventricular hemorrhage, but also increases the risk of sepsis. (See <a href=\"#H9\" class=\"local\">'Therapeutic roles'</a> above.) See associated topic reviews.</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li class=\"breakAll\">Traber MG. Vitamin E. In: Modern Nutrition in Health and Disease, Shils M, Olson J, Shike M, et al (Eds), Lippincott, Philadelphia 2000.</li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/2\" class=\"nounderline abstract_t\">Evans HM. The pioneer history of vitamin E. Vitam Horm 1963; 20:379.</a></li><li class=\"breakAll\">Mason, KE. The first two decades of vitamin E history. In: Vitamin E: A Comprehensive Treatise, Machlin, LJ (Eds), Marcel Dekker, New York 1980. p.1.</li><li class=\"breakAll\">Food and Nutrition Board of the Institute of Medicine. DRI Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids. National Academies Press, Washington DC, 2000. p. 186. Available at: http://books.nap.edu/catalog.php?record_id=9810#toc (Accessed on August 06, 2014).</li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/5\" class=\"nounderline abstract_t\">Wolf G. How an increased intake of alpha-tocopherol can suppress the bioavailability of gamma-tocopherol. Nutr Rev 2006; 64:295.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/6\" class=\"nounderline abstract_t\">Huang HY, Appel LJ. Supplementation of diets with alpha-tocopherol reduces serum concentrations of gamma- and delta-tocopherol in humans. J Nutr 2003; 133:3137.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/7\" class=\"nounderline abstract_t\">Burton GW, Joyce A, Ingold KU. Is vitamin E the only lipid-soluble, chain-breaking antioxidant in human blood plasma and erythrocyte membranes? Arch Biochem Biophys 1983; 221:281.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/8\" class=\"nounderline abstract_t\">Rimm EB, Stampfer MJ, Ascherio A, et al. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993; 328:1450.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/9\" class=\"nounderline abstract_t\">Jialal I, Fuller CJ, Huet BA. The effect of alpha-tocopherol supplementation on LDL oxidation. A dose-response study. Arterioscler Thromb Vasc Biol 1995; 15:190.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/10\" class=\"nounderline abstract_t\">Hodis HN, Mack WJ, LaBree L, et al. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. JAMA 1995; 273:1849.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/11\" class=\"nounderline abstract_t\">Stampfer MJ, Rimm EB. Epidemiologic evidence for vitamin E in prevention of cardiovascular disease. Am J Clin Nutr 1995; 62:1365S.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/12\" class=\"nounderline abstract_t\">Marchese ME, Kumar R, Colangelo LA, et al. The vitamin E isoforms &alpha;-tocopherol and &gamma;-tocopherol have opposite associations with spirometric parameters: the CARDIA study. Respir Res 2014; 15:31.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/13\" class=\"nounderline abstract_t\">Abdala-Valencia H, Berdnikovs S, Cook-Mills JM. Vitamin E isoforms as modulators of lung inflammation. Nutrients 2013; 5:4347.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/14\" class=\"nounderline abstract_t\">Jiang Q, Elson-Schwab I, Courtemanche C, Ames BN. gamma-tocopherol and its major metabolite, in contrast to alpha-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proc Natl Acad Sci U S A 2000; 97:11494.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/15\" class=\"nounderline abstract_t\">Hernandez ML, Wagner JG, Kala A, et al. Vitamin E, &gamma;-tocopherol, reduces airway neutrophil recruitment after inhaled endotoxin challenge in rats and in healthy volunteers. Free Radic Biol Med 2013; 60:56.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/16\" class=\"nounderline abstract_t\">Zingg JM, Azzi A. Non-antioxidant activities of vitamin E. Curr Med Chem 2004; 11:1113.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/17\" class=\"nounderline abstract_t\">Traber MG, Goldberg I, Davidson E, et al. Vitamin E uptake by human intestinal cells during lipolysis in vitro. Gastroenterology 1990; 98:96.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/18\" class=\"nounderline abstract_t\">Nakamura T, Aoyama Y, Fujita T, Katsui G. Studies on tocopherol derivatives: V. Intestinal absorption of several d,1-3,4-3H2-alpha-tocopheryl esters in the rat. Lipids 1975; 10:627.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/19\" class=\"nounderline abstract_t\">Cohn JS, McNamara JR, Cohn SD, et al. Postprandial plasma lipoprotein changes in human subjects of different ages. J Lipid Res 1988; 29:469.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/20\" class=\"nounderline abstract_t\">Cohn W, Loechleiter F, Weber F. Alpha-tocopherol is secreted from rat liver in very low density lipoproteins. J Lipid Res 1988; 29:1359.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/21\" class=\"nounderline abstract_t\">Yoshida H, Yusin M, Ren I, et al. Identification, purification, and immunochemical characterization of a tocopherol-binding protein in rat liver cytosol. J Lipid Res 1992; 33:343.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/22\" class=\"nounderline abstract_t\">Traber MG, Kayden HJ, Green JB, Green MH. Absorption of water-miscible forms of vitamin E in a patient with cholestasis and in thoracic duct-cannulated rats. Am J Clin Nutr 1986; 44:914.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/23\" class=\"nounderline abstract_t\">Soltani-Frisk S, Gronowitz E, Andersson H, Strandvik B. Water-miscible tocopherol is not superior to fat-soluble preparation for vitamin E absorption in cystic fibrosis. Acta Paediatr 2001; 90:1112.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/24\" class=\"nounderline abstract_t\">Winklhofer-Roob BM, van't Hof MA, Shmerling DH. Long-term oral vitamin E supplementation in cystic fibrosis patients: RRR-alpha-tocopherol compared with all-rac-alpha-tocopheryl acetate preparations. Am J Clin Nutr 1996; 63:722.</a></li><li class=\"breakAll\">Feranchak AP, Sokol RJ. Medical and nutritional management of cholestasis in infants and children. In: Liver disease in children, 3rd ed, Suchy FJ, Sokol RJ, Balistreri WF (Eds), Cambridge University Press, New York 2007. p.213.</li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/26\" class=\"nounderline abstract_t\">Sokol RJ, Butler-Simon N, Conner C, et al. Multicenter trial of d-alpha-tocopheryl polyethylene glycol 1000 succinate for treatment of vitamin E deficiency in children with chronic cholestasis. Gastroenterology 1993; 104:1727.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/27\" class=\"nounderline abstract_t\">Kowdley KV. Lipids and lipid-activated vitamins in chronic cholestatic diseases. Clin Liver Dis 1998; 2:373.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/28\" class=\"nounderline abstract_t\">Jeffrey GP, Muller DP, Burroughs AK, et al. Vitamin E deficiency and its clinical significance in adults with primary biliary cirrhosis and other forms of chronic liver disease. J Hepatol 1987; 4:307.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/29\" class=\"nounderline abstract_t\">Mu&ntilde;oz SJ, Heubi JE, Balistreri WF, Maddrey WC. Vitamin E deficiency in primary biliary cirrhosis: gastrointestinal malabsorption, frequency and relationship to other lipid-soluble vitamins. Hepatology 1989; 9:525.</a></li><li class=\"breakAll\">Lindor KD, Gershwin ME, Poupon R et al. AASLD Practice Guidelines, Primary Biliary Cirrhosis. Available at: http://www.aasld.org/practiceguidelines/Documents/Bookmarked%20Practice%20Guidelines/PrimaryBillaryCirrhosis7-2009.pdf (Accessed on April 25, 2012).</li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/31\" class=\"nounderline abstract_t\">Kalra V, Grover J, Ahuja GK, et al. Vitamin E deficiency and associated neurological deficits in children with protein-energy malnutrition. J Trop Pediatr 1998; 44:291.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/32\" class=\"nounderline abstract_t\">Ben Hamida M, Belal S, Sirugo G, et al. Friedreich's ataxia phenotype not linked to chromosome 9 and associated with selective autosomal recessive vitamin E deficiency in two inbred Tunisian families. Neurology 1993; 43:2179.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/33\" class=\"nounderline abstract_t\">Schuelke M, Mayatepek E, Inter M, et al. Treatment of ataxia in isolated vitamin E deficiency caused by alpha-tocopherol transfer protein deficiency. J Pediatr 1999; 134:240.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/34\" class=\"nounderline abstract_t\">El Euch-Fayache G, Bouhlal Y, Amouri R, et al. Molecular, clinical and peripheral neuropathy study of Tunisian patients with ataxia with vitamin E deficiency. Brain 2014; 137:402.</a></li><li class=\"breakAll\">Schuelke M. Ataxia with Vitamin E Deficiency. 2005 May 20 [Updated 2013 Jun 27]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews&reg; [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2014. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1241/.</li><li class=\"breakAll\">Sokol RJ. Vitamin E deficiency and neurological disorders. In: Vitamin E in Health and Disease, Packer L, Fuchs J (Eds), Marcel Dekker, New York 1993. p.815.</li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/37\" class=\"nounderline abstract_t\">Kumar N. Nutritional neuropathies. Neurol Clin 2007; 25:209.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/38\" class=\"nounderline abstract_t\">Robinson MH, Dowling BL, Clark JV, Mason CH. Brown bowel syndrome: an unusual cause of massive dilatation of the colon. Gut 1989; 30:882.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/39\" class=\"nounderline abstract_t\">Bia&#322;as M, Demczuk S, Dyduch G, et al. Brown bowel syndrome (intestinal lipofuscinosis) - a case report and review of the literature. Pol J Pathol 2013; 64:228.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/40\" class=\"nounderline abstract_t\">Oski FA, Barness LA. Vitamin E deficiency: a previously unrecognized cause of hemolytic anemia in the premature infant. J Pediatr 1967; 70:211.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/41\" class=\"nounderline abstract_t\">Natta C, Machlin L. Plasma levels of tocopherol in sickle cell anemia subjects. Am J Clin Nutr 1979; 32:1359.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/42\" class=\"nounderline abstract_t\">Ray D, Deshmukh P, Goswami K, Garg N. Antioxidant vitamin levels in sickle cell disorders. Natl Med J India 2007; 20:11.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/43\" class=\"nounderline abstract_t\">Walter PB, Fung EB, Killilea DW, et al. Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease. Br J Haematol 2006; 135:254.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/44\" class=\"nounderline abstract_t\">Rachmilewitz EA, Shifter A, Kahane I. Vitamin E deficiency in beta-thalassemia major: changes in hematological and biochemical parameters after a therapeutic trial with alpha-tocopherol. Am J Clin Nutr 1979; 32:1850.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/45\" class=\"nounderline abstract_t\">Jaja SI, Aigbe PE, Gbenebitse S, Temiye EO. Changes in erythrocytes following supplementation with alpha-tocopherol in children suffering from sickle cell anaemia. Niger Postgrad Med J 2005; 12:110.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/46\" class=\"nounderline abstract_t\">Hathcock JN. Vitamins and minerals: efficacy and safety. Am J Clin Nutr 1997; 66:427.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/47\" class=\"nounderline abstract_t\">Miller ER 3rd, Pastor-Barriuso R, Dalal D, et al. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005; 142:37.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/48\" class=\"nounderline abstract_t\">Bjelakovic G, Nikolova D, Gluud LL, et al. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev 2012; :CD007176.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/49\" class=\"nounderline abstract_t\">Finer NN, Peters KL, Hayek Z, Merkel CL. Vitamin E and necrotizing enterocolitis. Pediatrics 1984; 73:387.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/50\" class=\"nounderline abstract_t\">Brion LP, Bell EF, Raghuveer TS. Vitamin E supplementation for prevention of morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2003; :CD003665.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/51\" class=\"nounderline abstract_t\">Bieri JG, Corash L, Hubbard VS. Medical uses of vitamin E. N Engl J Med 1983; 308:1063.</a></li><li class=\"breakAll\">Trevithick JR, Robertson JM, Mitton KP. Vitamin E and the eye. In: Vitamin E in Health and Disease, Packer L, Fuchs J (Eds), Marcel Dekker, New York 1993. p.873.</li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/53\" class=\"nounderline abstract_t\">Tasman W, Patz A, McNamara JA, et al. Retinopathy of prematurity: the life of a lifetime disease. Am J Ophthalmol 2006; 141:167.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/54\" class=\"nounderline abstract_t\">Grundman M. Vitamin E and Alzheimer disease: the basis for additional clinical trials. Am J Clin Nutr 2000; 71:630S.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/55\" class=\"nounderline abstract_t\">Tabet N, Birks J, Grimley Evans J . Vitamin E for Alzheimer's disease. Cochrane Database Syst Rev 2000; :CD002854.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/56\" class=\"nounderline abstract_t\">Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol 2001; 119:1439.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/57\" class=\"nounderline abstract_t\">Evans JR. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Cochrane Database Syst Rev 2006; :CD000254.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/58\" class=\"nounderline abstract_t\">Lohr JB, Caligiuri MP. A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia. J Clin Psychiatry 1996; 57:167.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/59\" class=\"nounderline abstract_t\">Soares KV, McGrath JJ. Vitamin E for neuroleptic-induced tardive dyskinesia. Cochrane Database Syst Rev 2001; :CD000209.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-e/abstract/60\" class=\"nounderline abstract_t\">Albahrani AA, Greaves RF. Fat-Soluble Vitamins: Clinical Indications and Current Challenges for Chromatographic Measurement. Clin Biochem Rev 2016; 37:27.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 2582 Version 14.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H11\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">SOURCES</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">CHEMISTRY AND NOMENCLATURE</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">ACTIONS</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">METABOLISM</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">REQUIREMENTS</a><ul><li><a href=\"#H26561062\" id=\"outline-link-H26561062\">Healthy population</a></li><li><a href=\"#H26561069\" id=\"outline-link-H26561069\">Fat malabsorption</a></li></ul></li><li><a href=\"#H7\" id=\"outline-link-H7\">DEFICIENCY</a><ul><li><a href=\"#H3459898355\" id=\"outline-link-H3459898355\">Causes</a></li><li><a href=\"#H4250359426\" id=\"outline-link-H4250359426\">Clinical consequences</a></li></ul></li><li><a href=\"#H8\" id=\"outline-link-H8\">EXCESS AND TOXICITY</a></li><li><a href=\"#H9\" id=\"outline-link-H9\">THERAPEUTIC ROLES</a></li><li><a href=\"#H10\" id=\"outline-link-H10\">MEASUREMENT</a></li><li><a href=\"#H811983305\" id=\"outline-link-H811983305\">SOCIETY GUIDELINE LINKS</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"GAST/2582|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=PEDS/63827\" class=\"graphic graphic_table\">- Clinical symptoms of selected vitamin deficiencies</a></li><li><a href=\"image.htm?imageKey=PEDS/81151\" class=\"graphic graphic_table\">- Fat soluble vitamins Daily Recommended Intake</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=age-related-macular-degeneration-clinical-presentation-etiology-and-diagnosis\" class=\"medical medical_review\">Age-related macular degeneration: Clinical presentation, etiology, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=chemoprevention-strategies-in-prostate-cancer\" class=\"medical medical_review\">Chemoprevention strategies in prostate cancer</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=natural-history-and-management-of-nonalcoholic-fatty-liver-disease-in-adults\" class=\"medical medical_review\">Natural history and management of nonalcoholic fatty liver disease in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=nutritional-antioxidants-in-coronary-heart-disease\" class=\"medical medical_review\">Nutritional antioxidants in coronary heart disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-dietary-trace-minerals\" class=\"medical medical_review\">Overview of dietary trace minerals</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-the-hereditary-ataxias\" class=\"medical medical_review\">Overview of the hereditary ataxias</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-vitamin-a\" class=\"medical medical_review\">Overview of vitamin A</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-vitamin-d\" class=\"medical medical_review\">Overview of vitamin D</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-vitamin-k\" class=\"medical medical_review\">Overview of vitamin K</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-water-soluble-vitamins\" class=\"medical medical_review\">Overview of water-soluble vitamins</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pharmacotherapy-for-schizophrenia-side-effect-management\" class=\"medical medical_review\">Pharmacotherapy for schizophrenia: Side effect management</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-vitamin-deficiencies\" class=\"medical medical_society_guidelines\">Society guideline links: Vitamin deficiencies</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-dementia\" class=\"medical medical_review\">Treatment of dementia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=vitamin-supplementation-in-disease-prevention\" class=\"medical medical_review\">Vitamin supplementation in disease prevention</a></li></ul></div></div>","javascript":null}